CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition

作者：Xinwei Liu, Yiwen Lu, Jingying Huang, Yue Xing, Huiqi Dai, Liling Zhu, Shunrong Li, Jingwei Feng, Boxuan Zhou, Jiaqian Li, Qi‐Dong Xia, Jiang Li, Min Huang, Yuanting Gu, Shicheng Su · 发表于：Cancer Cell · 年份：2022 · DOI：10.1016/j.ccell.2022.10.015 · 被引用次数：59 · 研究领域：Monoclonal and Polyclonal Antibodies Research、Peptidase Inhibition and Analysis、HER2/EGFR in Cancer Research